Furthermore, a significant trend over time was observed for ICAM-1, sRAGE, and sTNFR-1, but this was not associated by low-dose steroid use, nor did their temporal evolution differ between treatment groups (Figure S4 ).
← all excerpts
Biomarkers trajectories in critically ill patients with COVID-19 acute respiratory distress syndrome: insights from latent class growth analysis.
1
—
—